Drug Cos. Question FDA Off-Label Communications Guidance
By Theresa Schliep · January 12, 2024, 5:31 PM EST
Recent guidance from the Food and Drug Administration addressing medical product companies' communications to healthcare providers about off-label uses of approved treatments goes too far, pharmaceutical and medical device companies said...
To view the full article, register now.